How To Master Big Data In Science

An IBM's executive Deborah DiSanzo just announced a collaboration with a pharmaceutical giant Pfizer to speed up anticancer drug discovery. This is yet another sign of a technological transformation unfolding in pharmaceutical industry. The newly formed partnership will bring the power of IBM's supercomputer Watson and its artificial intelligence system to help researchers at Pfizer advance "immuno-oncology", a potentially promising area for cancer research. Pfizer will use Watson's capabilities of machine learning, natural language processing, and other cognitive reasoning technologies to improve analysis of massive volumes of public and private datasets, including more than 30 million sources of laboratory and data reports, research articles, patents, and other medical literature. It is supposed to assist in testing research hypotheses and identify new promising therapeutic targets.